Ligand

Activities: Ingredients

Trending Articles

  1. NHS, MHRA and Medicines UK launch Project Revive to tackle medicine shortages NHS England, the MHRA and Medicines UK have launched Project Revive, a collaborative pilot designed to address critical medicines shortages by fast-tracking dormant...
  2. Isopod Rapid Cleanrooms: the ideal elite controlled environment pod solution for Life Sciences and Engineering start-ups The Guardtech Group’s quick-assembly cleanroom pods combine superior performance, build quality and cost-effectiveness to give new applications the perfect platform to get...
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    Delivering precision: why advanced therapies are redefining pharmaceutical logistics As advanced therapies narrow tolerances and personalise care, pharmaceutical logistics is being redefined as a precision-driven extension of treatment delivery, writes Michael...
  4. Nose-to-brain delivery outperforms systemic BBB technologies according to MetP Pharma The pioneering company has published preclinical data that strongly supports the advantages of its proprietary nose-to-brain drug delivery technology compared with systemic...
  5. AstraZeneca strengthens weight management pipeline with CSPC Pharmaceuticals collaboration The pair have signed a strategic collaboration covering eight obesity and type 2 diabetes programmes, including a clinical-ready GLP-1/GIP asset, AI-driven peptide discovery...

Upcoming event

High Shear = Mixing Success

19 February 2026 | Virtual See all

Related Content

Drug Delivery

Ligand's partner Travere announces FDA accelerated approval

First single molecule Dual Endothelin Angiotensin Receptor Antagonist (DEARA) approved for use in patients with IgA nephropathy (IgAN)
Ingredients

Therapeutic: sugemalimab for cancer immunotherapy:

Immunotherapy is an increasingly important component of anticancer therapy. A potential new treatment is being developed in China by CStone
Regulatory

Merck receives FDA approval for Vaxneuvance vaccine

The 15-valent pneumococcal vaccine using Ligand’s CRM197 vaccine carrier protein
Manufacturing

Hovione to support production of antiviral Veklury for COVID-19

Hovione has signed a partnership agreement with Ligand to significantly ramp up the production output of Captisol
Ingredients

Hovione links up with Ligand in Captisol agreement

Captisol improves the solubility and stability of drugs
Subscribe now